HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodies.
Open Access
- 1 August 1992
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 45 (8) , 726-727
- https://doi.org/10.1136/jcp.45.8.726
Abstract
Paraffin wax sections of 70 surgically resected colorectal adenocarcinomas were examined for the overexpression of HER2/c-erbB-2 oncoprotein using three different specific antibodies and the avidin-biotin immunoperoxidase technique. The patients included 38 men and 32 women aged between 47 and 80 years. The tumours were derived from various parts of the large intestinal tract, and represented all three stages of Dukes' classification and the three histological grades of differentiation. Many tumour sections also included adjacent normal or transitional mucosa. Eight tubular adenomas found in the colectomy specimens in association with some carcinomas were also examined. No positive membrane staining was seen in any of the 70 carcinomas, four adenomas, two hyperplastic polyps, nor in the adjacent normal or transitional mucosa. It is suggested that the overexpression of c-erbB-2 gene product is unlikely to be as common and as pronounced in colorectal adenocarcinoma as it is in ductal carcinoma of the breast.Keywords
This publication has 9 references indexed in Scilit:
- Oncoprotein stability after tumour resectionBritish Journal of Cancer, 1990
- Expression of the p185 encoded by her2 oncogene in normal and transformed human tissuesInternational Journal of Cancer, 1990
- CHARACTERIZATION OF MURINE MONOCLONAL-ANTIBODIES REACTIVE TO EITHER THE HUMAN EPIDERMAL GROWTH-FACTOR RECEPTOR OR HER2 NEU GENE-PRODUCT1990
- Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.Journal of Clinical Oncology, 1990
- c-erbB-2 oncoprotein expression in primary human tumorsCancer, 1990
- EXPRESSION OF THE C-ERBB-2 GENE-PRODUCT (P185) AT DIFFERENT STAGES OF NEOPLASTIC PROGRESSION IN THE COLON1989
- An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancerBritish Journal of Cancer, 1989
- SPORADIC AMPLIFICATION OF THE HER2/NEU PROTOONCOGENE IN ADENOCARCINOMAS OF VARIOUS TISSUES1988
- AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVOThe Lancet, 1986